Posted by Michael Wonder on 08 Dec 2020
TLV wants to go further with combination treatments in the field of cancer
7 December 2020 - Part of the solution for more patients to have access to combination treatments may be to create a national platform, where regions and companies can agree on different negotiation solutions in connection with two or more drugs being combined with each other.
This is the opinion of the Swedish Dental and Pharmaceutical Benefits Agency (TLV), in a new report.
